Advertisement
Coronavirus pandemic
WorldUnited States & Canada

Pfizer asks US to approve coronavirus vaccine for children aged 5 to 11

  • White House Covid-19 response coordinator Jeffrey Zients said the shots for kids could begin by November
  • Children currently make up about 27 per cent of all US coronavirus cases

1-MIN READ1-MIN
Pfizer has requested emergency use authorisation from the US FDA for its Covid-19 vaccine in children aged five to 11. Photo: AFP
Reuters
Pfizer Inc and BioNTech have asked US regulators to approve emergency use of their Covid-19 vaccine for children aged five to 11, Pfizer said in a tweet on Thursday.

The US Food and Drug Administration has set a date of October 26 for its panel of outside advisers to meet and discuss the application, making it possible for kids to begin receiving the vaccines soon afterwards.

A rapid authorisation of the vaccine in young kids could help mitigate a potential surge of cases this fall, with schools already open nationwide.

Advertisement

The vaccine could be ready for roll-out as early as November pending approval from federal regulatory health agencies, White House Covid-19 response coordinator Jeffrey Zients said on Thursday.

06:18

SCMP Explains: What’s in a Covid-19 vaccine?

SCMP Explains: What’s in a Covid-19 vaccine?

Once the authorisation is complete, Zients said: “We are ready. We have the supply. We’re working with states to set up convenient locations for parents and kids to get vaccinated including paediatricians’ offices and community sites.”

Advertisement
Advertisement
Select Voice
Select Speed
1.00x